Is orlistat medically essential for the treatment of obesity?
Fritze, J.
Versicherungsmedizin 51(1): 36-37
1999
ISSN/ISBN: 0933-4548 PMID: 10200615 Document Number: 504280
Obesity is a major health problem in western societies. The mainstay of therapy is behavioral modification. By inhibiting intestinal lipases orlistat modifies food composition. Thus, orlistat is a dietetic compound. Therefore, orlistat does not represent a medically necessary treatment option in terms of the conditions of private health insurances. However, adjunctive treatment with orlistat may make sense in single high risk patients.
Document emailed within 1 workday
Related Documents
Hendel, H.W.; Andersen, T. 1999: Orlistat: medically induced malabsorption of the fat in the treatment of severe obesity Ugeskrift for Laeger 161(44): 6068-6072Orozco, P. 1999: Does orlistat really offer help for the treatment of obesity? Atencion Primaria 24(8): 445-446
Micić, D.; Ivković-Lazar, T.; Dragojević, R.; Jorga, J.; Stokić, E.; Hajduković, Z. 1999: Orlistat, a gastrointestinal lipase inhibitor, in therapy of obesity with concomitant hyperlipidemia Medicinski Pregled 52(9-10): 323-333
Del Giudice, N.; Ghionni, A.; Colucci, M.; Palomba, D.; Jacono, G. 1971: Behavior of HGH in essential obesity and its changes after fasting Folia Endocrinologica 24(3): 281-286
Gragnoli, G.; Signorini, A.M.; Tanganelli, I.; Martinelli, G. 1979: Behavior of C-peptide and immunoreactive insulin in essential obesity Bollettino della Societa Italiana di Biologia Sperimentale 55(6): 564-570
Trovato, G.M.; Pace, P.; Martines, G.F.; Trovato, F.M.; Pirri, C.; Catalano, D. 2012: Stress, abdominal obesity and intrarenal resistive index in essential hypertension La Clinica Terapeutica 163(4): 299-305
Schönleben, K.; Bünte, H. 1976: Interventions in obesity. Small intestine bypass surgery in the treatment of extreme obesity Therapie der Gegenwart 115(9): 1468-1498
Kroustrup, J.P.; Larsen, J.F. 2001: Treatment of morbid obesity with laparoscopic, adjustable gastric banding. Results after two years of experiences with a new surgical method for severe obesity Ugeskrift for Laeger 163(7): 918-921
Marco, J.; Zabay, J.M.; García-Marco, M.A.; Gomez, G.; Mulet, J.M.; Munar, M.A.; Soler, J.; Viader, C. 2005: Angiotensinogen gene T174M polymorphism: opposite relationships with essential hypertension and obesity in a homogeneous population from Majorca (Baleric Islands, Spain) Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 25(6): 629-636
Wear, S.; Logue, G. 1995: The problem of medically futile treatment: falling back on a preventive ethics approach Journal of Clinical Ethics 6(2): 138-148
Joshua, I.B.; Passmore, P.R.; Sunderland, B.V. 2016: An evaluation of the Essential Medicines List, Standard Treatment Guidelines and prescribing restrictions, as an integrated strategy to enhance quality, efficacy and safety of and improve access to essential medicines in Papua New Guinea Health Policy and Planning 31(4): 538-546
Richards, W.O.; McRae, C. 2018: Comparative Analysis of Laparoscopic Fundoplication and Magnetic Sphincter Augmentation for the Treatment of Medically Refractory GERD American Surgeon 84(11): 1762-1767
Hakimi, R. 2015: Treatment of back pains with biophysical quantum medicine. Is the biofield test a medically necessary diagnostic technique? Versicherungsmedizin 67(2): 92-93
Strand, N.H.; Trentman, T.L.; Vargas, B.B.; Dodick, D.W. 2011: Occipital nerve stimulation with the Bion® microstimulator for the treatment of medically refractory chronic cluster headache Pain Physician 14(5): 435-440
Almas, K.; Awartani, F.A. 2003: Prevalence of medically compromised patients referred for periodontal treatment to a teaching hospital in Central Saudi Arabia Saudi Medical Journal 24(11): 1242-1245
Zhang, T.-T.; Ma, C. 2014: Related substances in orlistat detected with UPLC-MS/MS Yao Xue Xue Bao 49(3): 380-384
Petrogiannopoulos, C.; Kalogeropoulos, S.; Latsios, G.S.; Hartzoulakis, G.; Kalogeropoulos, G.; Zaharof, A. 2002: Orlistat use in overweight women with mild hypercholesterolemia International Journal of Clinical Pharmacology Research 22(3-4): 85-88
Ahmad, F.Asem.; Mahmud, S. 2010: Acute pancreatitis following orlistat therapy: report of two cases Jop: Journal of the Pancreas 11(1): 61-63
Zambrana García, J.L.; Cruz Caparrós, G.; Salas Coronas, J.; Díez García, F. 1999: Orlistat and articles accepted for publication in Medicina Clínica Medicina Clinica 113(18): 716
Decker, R.H.; Tanoue, L.T.; Colasanto, J.M.; Detterbeck, F.C.; Wilson, L.D. 2006: Evaluation and definitive management of medically inoperable early stage non-small-cell lung cancer. Part 2: newer treatment modalities Oncology 20(8): 899-905; Discussion: 905-908, 913